Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
21 Incredibly Entertaining Contemplations To Observe Consistently - 24 Energy-Proficient Clothes washers to Consider in 2024
- 3Telecommute Arrangement: What's Vital for Your Efficiency?
- 437 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- 523 Most Amusing Messages At any point Sent Among Kids and Their Folks
- 5 Worldwide Road Food sources You Should Attempt
- A Concise History Of The Entertainment world
- Manual for Picking the Ideal Wine Matching
- Tyler Childers' 'Snipe Hunt' 2026 Tour: How to get tickets, presale times, prices and more
- This Week In Space podcast: Episode 187 — An Inspired Enterprise
- From Representative to Business visionary: Private issue Victories
- Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
- Putting resources into Yourself: Self-awareness Techniques
- Toyota Motor Europe to roll out smart EV charging through new partnerships
